Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > News > Do-Coop Technologies Announces New Product

March 30th, 2006

Do-Coop Technologies Announces New Product

Abstract:
Do-Coop Technologies Ltd., a privately held corporation based in Israel, announced today the commercial availability of Neowater(TM) - ELISA Enhancer, a new product that increases immunoassay sensitivity and accuracy, while reducing total reaction costs. As with the entire Neowater-based product line, the ELISA Enhancer product is also generic, simple to use, and can be easily incorporated into any type of immunoassays with dramatic results.

Source:
businesswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015

Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015

Pens filled with high-tech inks for do-it-yourself sensors March 3rd, 2015

New nanodevice defeats drug resistance: Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs March 2nd, 2015

Announcements

CiQUS researchers obtain high-quality perovskites over large areas by a chemical method March 4th, 2015

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015

Nanosorbents Increase Extraction, Recycling of Silver from Aqueous Solutions March 4th, 2015

Black phosphorus is new 'wonder material' for improving optical communication March 3rd, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE